aTyr Pharma, Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from aTyr Pharma, Inc.'s yearly results (2022–2025), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Cash Cushion Ratio: Cash, after subtracting all debt, is 4.0 times its market value (net cash). Higher than almost all Healthcare companies in United States.
- Steadiness Ratio: Sales and profit both fell in each of the last 3 years. Less steady than 96% of Healthcare companies in United States.
Cash quality
Profit Cash Ratio
—Loss-making or profit too small
Over the last 3 years profit was a loss or under 2% of sales, so cash per 100 of profit is not meaningful.
Self-Funding Ratio
-37.7×Over the last 3 years operating cash was negative while the company kept spending on investment (capex).
Lower than 68% of Healthcare companies in United States.
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
0/3 · 0/3Sales and profit both fell in each of the last 3 years.
Less steady than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
—Sales fell 98%
Sales fell 98% in 3 years, so extra profit per extra sales cannot be measured.
Asset Productivity Ratio
-98% / -3%In 3 years sales changed by -98% while total assets changed by -3%. Assets grew faster than sales.
Balance-sheet strength
Debt Due Cover Ratio
-42.3×Operating cash was negative last year, while some debt falls due within a year.
Lower than 69% of Healthcare companies in United States.
Cash Cushion Ratio
4.0× cashCash, after subtracting all debt, is 4.0 times its market value (net cash).
Higher than almost all Healthcare companies in United States.
Tangible Assets Ratio
—Data incomplete
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (12)
aTyr Pharma, Inc. made a loss over the last year. aTyr Pharma, Inc. owes $0.30 for every $1 it owns. aTyr Pharma, Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossaTyr Pharma, Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
0.34The share price is 0.34 times aTyr Pharma, Inc.'s book value per share, lower than 95% of Healthcare companies in United States.
Market cap
$17 MThe total market value of all of aTyr Pharma, Inc.'s shares at today's price (share price × number of shares), smaller than 83% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$49 MWhat aTyr Pharma, Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$0.50Net worth divided by the number of shares. The share price of $0.17 is 0.3 times this, which is the P/B above.
Return on equity (ROE)
-98.7%aTyr Pharma, Inc. lost 98.7% of its shareholders' money over the last year, lower than 70% of Healthcare companies in United States.
Owes vs Owns
0.30×aTyr Pharma, Inc. owes $0.30 for every $1 it owns (low), lower than 60% of Healthcare companies in United States.
Dividend yield
NoneaTyr Pharma, Inc. does not currently pay a dividend.
Revenue growth
-19%Revenue fell 19% in the year to Dec 2025, and shrank 74% a year on average over 3 years.
Profit growth
LossaTyr Pharma, Inc. made a loss in each of the last two years.
Profit margin
-39009.5%aTyr Pharma, Inc. lost $39009 for every $100 of revenue.
Cash vs debt
Net cashaTyr Pharma, Inc. held $67 M more cash than debt (net cash) at Dec 2025.
Questions
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For aTyr Pharma, Inc.: $17 M ÷ $49 M (30 Jun 2026) = 0.3.
What is aTyr Pharma, Inc.'s return on equity?
aTyr Pharma, Inc. lost 98.7% of its shareholders' money over the last year, lower than 70% of Healthcare companies in United States.
How much does aTyr Pharma, Inc. owe compared with what it owns?
aTyr Pharma, Inc. owes $0.30 for every $1 it owns (low), lower than 60% of Healthcare companies in United States.
Does aTyr Pharma, Inc. pay a dividend?
No. aTyr Pharma, Inc. does not currently pay a dividend.
Is aTyr Pharma, Inc.'s revenue growing?
Revenue fell 19% in the year to Dec 2025, and shrank 74% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.